S. THOMAS ANDERSON, District Judge.
Before the Court is the government's Motion for Summary Judgment (D.E. # 22) filed on December 12, 2011. Defendants American Mercantile Corporation, Ingredients Corporation of America, and Damon S. Arney have filed a response in opposition to Plaintiff's Motion. The government has filed a reply, and Defendants have filed a sur-reply. For the reasons set forth below, Plaintiff's Motion is
The following facts are not in dispute for purposes of this Motion unless otherwise noted. This case involves alleged violations of the Food, Drug, and Cosmetic Act ("FDCA"). Defendant American Mercantile Corporation ("AMC") is a Tennessee corporation, which currently lists its principal
Defendant Ingredients Corporation of America a/k/a Barzi Brand ("ICA") is a Tennessee corporation and subsidiary of AMC that currently conducts its operations at 1270 Warford Street, Memphis, Tennessee. (Compl. ¶ 4; Answer ¶ 4; Schafer Decl. ¶ 5 & Ex. A-2.)
Defendant Damon S. Arney ("Arney") is the owner and president of AMC and ICA. (Compl. 5; Answer ¶ 5; Schafer Decl. ¶ 6.) He is responsible for overseeing all areas of operations and has the duty, power, responsibility, and authority to detect, prevent, and correct the insanitary conditions at AMC and ICA. (Id.; see also Bradley Decl., ex. B, ¶ 8.)
The parties disagree about the exact nature of each Defendant's enterprise. According to the government, both Defendants receive, process, manufacture, prepare, pack, label, hold, and distribute a wide variety of food products and ingredients, including spices, spice blends, seeds, herbs, and sauces. (Compl. ¶¶ 3-4; Answer ¶¶ 3-4; Schafer Decl. ¶¶ 4-5.) Defendants assert that AMC's primary business is to import and supply bulk botanical products that are then sold to large food or non-food manufacturers. (Arney Decl. ¶ 2.) AMC also sells numerous crude and semiprocessed botanicals to manufacturers that "further process" these materials in order to meet food grade requirements. (Id. ¶ 7.) By contrast, ICA purports to be primarily a spice manufacturer that produces goods, such as barbecue dry rubs, for sale to customers that then sell the goods in retail distribution or to customers who utilize the spice blends in their cooking or processing operations. (Id. ¶ 8.) It is undisputed that both corporate Defendants ship their food products and ingredients to sources located outside of the state of Tennessee. (Compl. ¶¶ 7, 11; Answer ¶¶ 7, 11; Schafer Decl. ¶¶ 4-5, 12, 15, 18, 21; exs. A-13, A-20, A-21, A-34, A-35; Bradley Decl. ¶¶ 6-7, 11, 15; exs. B-5, B-8.)
According to the government, Defendants are repeat violators of the FDCA whose unsanitary practices, including the failure to exclude rodents and insects from its facilities and food, have necessitated previous action by this Court.
The FDA conducted an inspection of AMC's Farmville Road facility between March 10 and 13, 2009. As a result of this inspection, the FDA issued a five-item Form FDA-483, List of Inspectional Observations ("Form FDA-483"). (Schafer Decl. ¶ 13; ex. A-14.) Specifically, the FDA inspectors reported failures to comply with current good manufacturing practice ("cGMP"), including, but not limited to the following:
Specifically, the inspectors found fiberglass insulation hanging from the ceiling above open burlap bales of an unknown botanical product. (Id.; ex. A-14.)
On March 13, 2009, Defendant Arney addressed a letter to the FDA, stating that the firm was closing the week of March 16, 2009, to correct the violations reported from the inspection. (Schafer Decl. ¶ 13; ex. A-16.) After the voluntarily shutdown, the FDA conducted a follow-up inspection of AMC's Farmville Road facility between March 26 and 27, 2009. (Id.) FDA investigators issued another five-item Form FDA-483 to Defendants after the March 26 and 27, 2009 inspection, finding similar insanitary conditions despite Defendant AMC and Arney's efforts to clean the facility and promises to correct the violations. (Schafer Decl. ¶ 13; exs. A-17, A-18.)
FDA investigators collected samples during both of the March 2009 inspections of AMC's Farmville Road facility. (Schafer Decl. ¶ 14; exs. A-19, A-20, A-21, A-25). One sample collected during the second inspection was taken from an area AMC claimed to have cleaned. (Id.) Even so, FDA laboratory analysis confirmed the presence of filth, including rodent and insect filth, in the samples collected before
In May 2009 the U.S. Marshals Service seized adulterated food products at AMC pursuant to a Warrant In Rem issued in United States v. 35/15 kg poly mesh bags, Civ. A. No. 09-2271-SHM/dkv (W.D.Tenn. May 1, 2009) (Consent Decree, ex. C; Schafer Decl. ¶ 7.) Thereafter, Defendant Arney, on behalf of AMC, entered into a Consent Decree of Condemnation ("the Consent Decree"), which was signed by U.S. District Judge Samuel H. Mays, Jr., on June 16, 2009. (Id.) Under the Consent Decree, AMC admitted and the Court adjudged that food was "held under insanitary conditions whereby it may have been contaminated with filth." (Consent Decree ¶ 2.) AMC was required to either bring the seized food into compliance (i.e. recondition it) or destroy it. (Id. ¶ 10.)
AMC attempted to recondition the products; however, its efforts were insufficient. (Schafer Decl. ¶ 7.) Specifically, the FDA investigators conducted a walk through at AMC in July 2009, to determine whether pests had been excluded from the facility, as was required before reconditioning efforts could begin. (Id. & ex. A-3.) The FDA documented eight separate areas where live insects were present. (Id.)
The FDA's most recent inspection of AMC's Farmville Road facility was conducted between October 12 and 22, 2010, for the purpose of assessing Defendants' current compliance with the FDCA. (Schafer Decl. ¶ 10; Bradley Decl. ¶ 9.) Defendants respond that they cannot address the FDA's reasons for conducting the October 2010 inspection. (Defs.' Resp. to Statement of Fact ¶ 13.) Defendants further emphasize that AMC no longer conducts any operations of any kind at the Farmville Road facility and stores all products at three independent warehouses: one in Memphis and two in New Jersey, all of which are registered with and regulated by the FDA. (Arney Decl. ¶ 6.)
(a) AMC failed to take effective measures to protect against the contamination of foods with pests. See 21 C.F.R. § 110.35(c) (repeat observation) (Bradley Decl. ¶ 9(a); ex. B-1, pp. 6-14, photos 10-26.) Investigators observed live and dead insects throughout the facility around products, on the exterior packaging of products, and in products. (Id.) For example, investigators noted insects in kola nuts and sweet orange peel powder, as well as on top of boxes containing those products. (Id.) Also, investigators found insects on the exterior of a tub containing slippery elm bark, on packaged graviola leaves, and on the exterior packaging of dehydrated granulated garlic grain. (Id.) Moths also were observed flying around products and on the exterior packaging of products, along with cobwebs and live spiders. (Id.)
(b) AMC failed to provide adequate screening or other protection against pests. See 21 C.F.R. § 110.20(b)(7) (repeat observation). (Bradley Decl. ¶ 9(b); ex. B-1, pp. 15-16, photos 27-29.) For example, investigators observed a gap approximately two inches wide at the juncture between the roof and a wall leading to the exterior of the building, and a door with a gap revealing sunlight down the entire right-hand side and across the bottom. (Id.) Two exhaust fans in the ceiling of the manufacturing area, which led to the exterior, also were observed without screens. (Id.)
(c) AMC's Farmville Road facility was not constructed in a manner so as to prevent drip or condensation from contaminating food, food-contact surfaces, and food-packaging materials. See 21 C.F.R. § 110.20(b)(4). (Bradley Decl. ¶ 9(c); ex. B-1, pp. 17-18, photos 30-32.) Investigators observed that a black substance, which AMC employees identified as roof tar, had dripped from the ceiling onto food products, food-packaging, and surfaces of the facility. (Id.)
(d) AMC failed to store raw materials and other ingredients in a manner that would protect against contamination. See 21 C.F.R. § 110.80 (repeat observation). (Bradley Decl. ¶ 9(d); Ex. B-1, pp. 18, photo 33.) For example, investigators observed slippery elm bark in a storage container on an exterior dock with the container door open during the entire time they were present on October 20 and 21, 2010. (Id.) Investigators also observed clover hay stored on an exterior dock during all days they were present. (Id.)
(e) AMC failed to operate fans and other air-blowing equipment in a manner that minimized the potential for contaminating food, food-contact surfaces, and food-packaging
(f) AMC's facility was not constructed in a manner so as to allow walls and ceilings to be adequately cleaned and kept clean. See 21 C.F.R. § 110.20(b)(4). (Bradley Decl. ¶ 9(f); ex. B-1, pp. 19-20, photos 35-37.) The investigators saw a crack, running from the ceiling to about halfway down a wall, that was filled with foam, as well as exposed insulation in the ceiling of the front room. (Id.)
(g) AMC failed to provide safety-type light bulbs over exposed food. See 21 C.F.R. § 110.20(b)(5). (Bradley Decl. ¶ 9(g); ex. B-1, p. 21, photo 38.) The investigators saw an unshielded light bulb suspended above kola nuts that were packaged in damaged, poly-woven bags. (Id.)
FDA investigators collected four samples (with more than seventy sub-samples) at AMC's Farmville Road facility to document the insanitary conditions during the October 2010 inspection. (Schafer Decl. ¶ 11; Bradley Decl. ¶ 10; exs. B-2, B-3, B-4, B-5.) FDA laboratory analysis of those samples confirmed the presence of insects and other filth. (Schafer Decl. ¶ 11; exs. A-9, A-10, A-11, A-12; Tucker Decl.; ex. D, ¶ 15.)
Defendants challenge the validity of the underlying violations the FDA documented in the October 2010 inspection. Defendants contend that the products evidencing insect activity were actually received in a shipment only a few days prior to the FDA inspection. (Arney Decl. ¶ 5.) Upon receipt of the shipment and before the FDA inspection commenced, AMC employees discovered that much of the merchandise was contaminated with insects, prompting AMC to elect to destroy the products. (Id.) Defendants state that arrangements were made for the delivery of a dumpster where AMC could dispose of the contaminated products. (Id.) Due to the volume of affected goods, AMC had to have the dumpster emptied and returned several times in order to dispose of all of the products. (Id.) According to Defendants, the dumpster was full when the FDA inspectors arrived. (Id.) Importantly, Defendants maintain that the FDA inspectors took samples from the discarded products and reported the findings in their Form FDA-483. (Id.)
AMC claims that as a result of the contamination of these goods, AMC immediately ceased doing business with the warehouse facility where the infested shipment had originated. (Id.) Defendant Arney affirms that in the aftermath of the October 2010 inspection, he also reorganized the manner in which AMC conducted its business. (Id. ¶ 6.) According to Arney, he made the decision to discontinue any storage or processing of goods at AMC's Farmville Road facility. (Id. ¶ 7.) Now AMC never takes physical possession of the goods it sells or processes the goods in any way for its customers. (Id. ¶¶ 6, 7.) Rather, when AMC makes a sale, the goods ship to the customer from one of three independent warehouse facilities. (Id. ¶ 7.) Furthermore, in light of its new operations model, AMC terminated all of its employees except for one individual who was reassigned to ICA. (Id.)
The FDA inspected ICA's Huron Avenue facility between May 11 and 12, 2004.
The FDA returned to inspect ICA's Huron Avenue facility between June 9 and 17, 2009. (Schafer Decl. ¶ 19 & ex. A-32.) The eight-item Form FDA-483 issued to Defendants reported the following violations among others:
(a) ICA failed to take effective measure to protect against contamination of food by pests (as evidenced by numerous REPs and live and dead insects). (Id.; ex. A-29, pp. 1-4, photos 1-7; ex. A-30, pp. 1-43, photos 1-85.)
(b) ICA failed to prevent drip or condensation from contaminating food (as evidenced by food stored under a roof leak). (Id.; ex. A-30, pp. 43-44, photos 86-88.)
(c) ICA failed to receive and store raw materials in a manner which protected against contamination (as evidenced by products with moisture-staining, mold, and holes). (Id.; ex. A-30, pp. 43-44, 47-49, photos 86-88, 93-96.)
(d) ICA failed to provide adequate screening or other protection against pests (as evidenced by gaps under doors). (Id.; ex. A-30, pp. 45-46, photos 89-91.)
Furthermore, investigators collected three samples (with sub-samples) at the June 2009 inspection of the Huron Avenue facility. (Schafer Decl. ¶ 20; exs. A-33, A-34, A-35). FDA laboratory analysis of these samples confirmed the presence of rodent and insect filth. (Schafer Decl. ¶ 20; exs. A-36, A-37, A-38; Tucker Decl. ¶ 40.) On January 5, 2010, the FDA issued a letter to ICA, warning that the FDA's June 2009 inspection of the Huron Avenue facility had revealed insanitary conditions that caused foods stored there to be adulterated and explaining that it was ICA's responsibility to correct those conditions. (Schafer Decl. ¶ 25; ex. A-40.)
Defendants highlight the fact that ICA no longer conducts operations of any kind at the Huron Avenue facility and has operated exclusively at the 1270 Warford Street facility since the fall of 2010. (Arney Decl. ¶¶ 8, 10, 12.) The FDA conducted an inspection of ICA's Warford Street facility between November 1 and 8, 2010, in follow-up to the earlier inspection of ICA's former Huron Avenue facility. (Schafer Decl. ¶ 16; Bradley Decl. ¶ 13.)
(a) ICA failed to take effective measures to protect against contamination of food by pests. See 21 C.F.R. § 110.35(c) (repeat observation). (Bradley Decl. ¶ 13(a).) Investigators noted numerous live and dead insects, as well as evidence of rodent activity around products, on the exterior packaging of products, and in products. (Id.) For example, investigators observed REPs and rodent hairs on boxes of granulated garlic and underneath a storage rack. (Id.) In addition, investigators observed insects on boxes of dehydrated green bell peppers, in the inner folds and neck of a plastic bag containing ground fennel, on and in a closed plastic bag containing lemon peel powder, and on chopped onion product. (Id.) Investigators noted dead insects adhering to tape used to close products, including a bag of bread crumbs, a box of beet root powder, a bag of dry whey, and a box of organic tomatoes. (Id.) Defendants dispute that the Form FDA-483 documents any evidence of rodent activity in products. Defendants further argue that the FDA laboratory results from this inspection concluded that, aside from two insects in a Beatreme sample, no product was actually contaminated with rodent or insect filth. (Schafer Decl., ex. A-27, A-28).
(b) ICA failed to clean food-contact surfaces and equipment as frequently as necessary to protect against contamination of food. See 21 C.F.R. § 110.35(d)(1) & (3). (Bradley Decl. ¶ 13(b).) Specifically, investigators observed rust inside two mixers used in processing dry food products and mold on the exterior lid of a kettle used for mixing and cooking barbeque sauce. (Id.) Defendants dispute the FDA's findings about the presence of rust and mold on their equipment. With respect to the rust, Defendants argue that the mixer in question is an industrial capacity, stainless steel machine, approximately 4 feet by 10 feet in size and capable of mixing 1,000 pounds of material. (Pratt Decl. ¶ 14.) Defendants dispute that the substance observed on the mixer was rust and claim that it was only the size of a dime and could only have been residue left from the previous use of the mixer. (Id.) Defendants further assert that ICA's standard operating procedure requires that each mixer be cleaned before and after each use with a food grade cleaning agent. (Id.; Arney Decl. ¶ 15.) Douglas Pratt, the general manager of ICA, was present during the inspection and attempted to explain the likely cause of the residue to the FDA inspector but to no avail. (Pratt Decl. ¶ 14.) As for the mold, Defendants deny that mold was present in the sauce room at the Warford Street facility. (Id. ¶ 15.) The discoloration observed by the FDA inspector was simply dust created by the ongoing construction in that part of the facility. (Id.) Defendants assert that construction workers were present in the room on the date of the inspection and that no food production had occurred in the room at that time. (Id.; Arney Decl. ¶ 15.)
(c) The investigators saw an employee with hair hanging outside of his hairnet, see 21 C.F.R. § 110.10(b)(6), as he leaned over a bulk container of garlic butter blend and hand-filled it into plastic boxes. (Bradley Decl. at ¶ 13(c).) Defendants deny that any violation occurred. Defendants identify the employee as Delaney Boone, an African-American whose hair was braided and in a hairnet at the time of the inspection. (Pratt Decl. ¶ 16.) According to Defendants, one of the employee's braids at the back of his neck came out of the hairnet while he was working, and this was the basis for the inspector's finding. (Id.)
The United States filed its Complaint for Permanent Injunction on May 11, 2011, seeking injunctive relief for Defendants' alleged violations of the FDCA. The parties have reported to the Court that before filing suit and even up until the summary judgment stage, they engaged in negotiations to attempt a settlement but without success. Then, on December 2, 2011, Defendants filed a motion for court-ordered mediation and an extension of deadlines (D.E. # 20), which the government opposed, and the Court ultimately denied. (See Order Denying Defs.' Mot. for Court-Ordered Mediation Jan. 20, 2012, 2012 WL 174930, D.E. # 32.) However, before the Court could take up Defendants' motion for mediation, the United States filed the instant Motion for Summary Judgment. In response Defendants filed a motion for discovery pursuant to Rule 56(d) (D.E. # 33), seeking an opportunity conduct limited discovery, which Defendants claimed was needed to respond to the Motion for Summary Judgment. While their motion for discovery was pending, Defendants filed a response in opposition to the Rule 56(a) Motion. On May 29, 2012, the Court conducted a hearing on Defendants' motion for discovery and later denied the motion, concluding that Defendants had failed to show with specificity what additional information discovery would reveal. (See Order Denying Defs.' Mot. for Disc. June 18, 2012, D.E. # 47.) The Court did grant Defendants an opportunity to file a sur-reply in opposition to the Motion for Summary Judgment.
The government now seeks judgment as a matter of law on Defendants' alleged violations of the FDCA. The United States argues that Defendants violated 21 U.S.C. § 331(a) and (k), meaning that the government has the burden to prove that (1) Defendants' products are "food" within the meaning of the Act; (2) that the food was "adulterated" as the FDCA defines that term; and (3) that the food moved in interstate commerce. According to the United States, no genuine issue of material fact exists as to any element in this case, making summary judgment proper. The government contends that the Court may take judicial notice of the fact that Defendants' products are "food," which the FDCA defines to mean "(1) articles used for food or drink for man or other animals, (2) chewing gum, and (3) articles used for components of any such article." The government further argues that Defendants admit their products travel in interstate commerce, thereby satisfying this element. Finally, the United States claims that Defendants'
In their response in opposition, Defendants largely focus their arguments on the likelihood of future violations of the Act, a factor Defendants claim the government has failed to prove. Defendants emphasize that since the FDA's most recent inspections, both corporations have changed the manner in which they conduct business. With respect to AMC, Defendants state that AMC no longer utilizes the Farmville Road facility for any purpose and has completely altered its operations model. Rather than storing and processing goods at its own facility, AMC now receives shipments at third-party warehouses, one in Tennessee and two in New Jersey, all of which are "FDA licensed." AMC also briefly suggests that its operations do not involve food products but rather "raw agricultural commodities," which are not covered by the FDCA. As for ICA, Defendants argue that ICA no longer operates at the Huron Avenue facility but has now completely moved all of its operations to the newly refurbished Warford Street facility. Defendants also cite a number of other remedial actions taken to correct the problems associated with ICA's operations at the former Huron Avenue facility. Defendants highlight that the Tennessee Department of Agriculture ("TDA") conducted a more recent inspection of the Warford Street facility in June 2011 and found no evidence that food was being held under insanitary conditions. According to Defendants, not only can the government not prove a likelihood of future violations, the government must also satisfy the other three factors in the traditional balancing test for injunctive relief. Defendants maintain that a court sitting in equity need only dispense with the full balancing test where Congress requires issuance of an injunction for statutory violations, as opposed to giving the court discretion to issue the injunction. Defendants argue that the FDCA merely gives the Court discretion to issue injunctive relief, and so the four-factor test should apply. For these reasons, Defendants argue that a permanent injunction is not warranted.
In its reply, the government argues that Defendants have conceded or admitted all of the facts that go to establish their violations of the FDCA. Moreover, the entire record of violations at Defendants' facilities suggests that only court oversight will ensure that Defendants achieve and maintain compliance with the Act. The government also reiterates its argument that it need only prove that violations have occurred and that without injunctive relief are likely to occur again in the future. In response to the remedial measures undertaken by Defendants, the government points out that the expert Defendants hired to address their compliance issues was retained in the spring of 2009. As the FDA's findings from October and November
Finally, Defendants have filed a sur-reply in which they emphasize (1) AMC's complete reorganization of its business to discontinue actual handling any foods; (2) ICA's investment in the new Warford Street facility; (3) the fact that the FDA has not returned to inspect the Warford Street facility since late 2010; and (4) the fact that ICA passed a more recent TDA inspection in June 2011.
Federal Rule of Civil Procedure 56(a) provides that a party is entitled to summary judgment if the moving part "shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law."
Summary judgment must be entered "against a party who fails to make a showing sufficient to establish the existence of an element essential to that party's case, and on which that party will bear the burden of proof at trial."
For the reasons that follow, the Court holds that Plaintiff is entitled to judgment
The United States alleges that Defendants have violated 21 U.S.C. § 331(a) & (k). Section 331(a) prohibits "the introduction or delivery for introduction into interstate commerce of any food ... that is adulterated...."
It is undisputed that both AMC and ICA are Tennessee corporations and that AMC is the parent corporation of ICA. Both corporations currently have their principal place of business at the same address, 1270 Warford Street, Memphis, Tennessee. Both corporations have as their owner and president Defendant Damon S. Arney. As a threshold matter, the Court must determine whether all of each corporation's past violations of the FDCA can be imputed to both corporations as a matter of law. In other words, the issue presented is whether AMC should be held liable for the violations committed by ICA (and vice versa).
Concerning the corporate Defendants, the United States makes no distinction between the two entities in the Motion for Summary Judgment. For example, the government refers to "Defendants" collectively and cites all of the prior inspections and reported violations at both businesses as proof that "Defendants" have violated the law (as well as proof of the likelihood of future violations, an issue that goes to the need for permanent injunctive relief). In effect, the government treats all of the violations as a single pattern or practice carried out by a joint enterprise.
However, the United States cites no authority for the proposition that the FDCA violations of one corporation can be imputed to another corporation, even in the parent-subsidiary context. The Supreme Court has remarked that "it is a general principle of corporate law deeply ingrained in our economic and legal systems that a parent corporation (so-called because of control through ownership of another corporation's stock) is not liable for the acts of its subsidiaries."
Likewise, nothing in the language of the FDCA itself indicates a congressional intent to hold both parent and subsidiary liable for only one corporation's violations
The Court finds the Supreme Court's reasoning in Bestfoods persuasive and concludes that the same analysis should apply to the issue presented in the case at bar. For the reasons already discussed, the Court begins with the common law presumption that both parent and subsidiary cannot be liable for the acts of only one of the corporations in the parent-subsidiary relationship. Upon examination of the statutory text of the FDCA, there is no evidence that Congress enacted the FDCA with the intent to alter or displace "well-settled" common law rules on corporate liability.
The Court recognizes the possible argument that under the FDCA, a parent corporation might be liable for violations of the subsidiary (or vice versa) if it could be shown that the parent exercised some degree of control over the acts of the subsidiary.
Even considering all of the evidence separately as to each Defendant, the Court concludes that the government is entitled to summary judgment on AMC's violations of the Act. As previously discussed, the government must prove that AMC's products are food; the food was adulterated; and the food will move (or has moved) in interstate commerce. For purposes of summary judgment, AMC concedes the interstate element. As a result, the only elements actually in dispute are whether AMC's products are "food" and whether the "food" was "adulterated," as the FDCA defines these terms.
With respect to the first issue, the Court holds that AMC's products included "food" for purposes of the Act. As previously mentioned, the FDCA defines the term "food" to mean "(1) articles used for food or drink for man or other animals, (2) chewing gum, and (3) articles used for components of any such article."
The Court need not resolve the parties' arguments. AMC has admitted in its answer that its products were "foods" for purposes of the Act. The Complaint alleges at paragraph 6 that both Defendants' "products are food within the meaning of the Act, 21 U.S.C. § 321(f)."
The only remaining issue then is whether AMC's food is "adulterated." In order to satisfy its burden, the government must prove that AMC's food "has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health."
Based on the results of the October 2010 inspection of AMC's Farmville Road facility, the government has proven a reasonable probability of contamination with filth as to food stored there at that time. The Form FDA-483
The only violation AMC actually disputes is the finding related to the presence of pests and actual contamination. AMC claims that the pests were observed in products, which were delivered a short time before the inspection and were already marked for disposal, though AMC has not adduced evidence showing which products were received in this condition.
Taken together with the other uncontested violations observed during the October 2010 inspection and under the totality of the circumstances, the Court holds that the government is entitled to summary judgment on the issue of whether AMC adulterated food in violation of the FDCA. The reported violations give rise to a reasonable possibility of contamination at the Farmville Road facility, and Defendants have not raised any issues of material fact to dispute the evidence presented by the United States.
The Court next considers whether the government is entitled to judgment as a matter of law against ICA for violations reported during the November 2010 inspection of the Warford Street facility. For purposes of summary judgment, it is undisputed that ICA's products are "food" as the Act uses the term and that the food moved in interstate commerce. The only disputed issue concerns whether the food was "adulterated."
The FDA Form-483 from reported the following violations from the November 2010 inspection: (1) pest and rodent activity in and around food products in violation of 21 C.F.R. § 110.35(c); (2) suspected signs of rust and mold in food prep areas in violation of 21 C.F.R. § 110.35(d)(1) & (3); and (3) an employee with hair hanging out of his hairnet in violation of 21 C.F.R. § 110.10(b)(6). Based on these conditions, the government argues that ICA violated the Act and that summary judgment is warranted. In response ICA contests two of the three findings, the observations of rust and mold and the employee's hairnet. The Court holds that questions of fact remain about these two alleged violations, precluding judgment as a matter of law on those issues. Nevertheless, ICA does not seriously dispute the FDA's most damaging findings about pest and rodent activity. Therefore, the Court holds that the United States is entitled to summary judgment as to that violation.
Viewing the evidence in the light most favorable to ICA, a reasonable juror could find that the FDA has not proven all of the alleged violations observed during the November 2010 inspection. First, the investigators
As for the employee's hair, the regulation at issue requires that "plant management shall take all reasonable measures and precautions to ensure ... cleanliness."
Viewing the evidence in the light most favorable to ICA, genuine questions of fact remain about whether ICA violated this regulation. The evidence shows that the employee was wearing a hair net and that some of his hair, which was in a long braid, came out of the net. The government has not shown that the hair net was not being worn "in an effective manner" or that the hair momentarily coming out of the restraint is ipso facto a violation of the regulation. Without additional proof, a reasonable fact finder could conclude that no violation of 21 C.F.R. 110.10(b)(6) actually occurred. Thus, the Court concludes that summary judgment would not proper for this violation.
Even though the United States is not entitled to judgment as matter of law on all of the reported violations, ICA has not challenged what are arguably the most damaging findings from the November 2010 inspection: the presence of insects and signs of rodent activity in and around products. As previously discussed, an enterprise has a duty under the regulations to exclude pests from any area on the premises where food is held or processed. ICA has not introduced any evidence to dispute that insect and rodent activity was detected during the inspection. ICA simply argues that lab analysis of samples taken during the inspection did not reveal actual contamination. This contention ignores the fact that proof of actual contamination is not required; the FDCA is violated when food becomes adulterated, meaning there is a reasonable probability of contamination. Courts have repeatedly held that the presence of insects and rodents in a food processing facility creates a reasonable probability of contamination.
Having concluded as a matter of law that both AMC and ICA violated the FDCA, the Court turns to the issue of whether Defendant Arney can be held liable for his role in allowing the violations committed by these enterprises to occur. The Supreme Court has held that officers or managers of a business organization, which is found to be in violation of the FDCA, are themselves liable for the violations.
As the Sixth Circuit has recognized, the FDCA provides only three remedies for violations: (1) injunctive relief, 21 U.S.C. § 332; (2) criminal prosecution, 21 U.S.C. § 333; and (3) seizure, 21 U.S.C. § 334.
(1) Defendants must destroy at their own expense and under FDA supervision all articles of food and food ingredients in their custody, control, or possession within thirty days of the entry of the Court order.
(2) Defendants must conduct at their own expense a comprehensive cleaning and fumigation effort to rid their facilities of all pests.
(3) Defendants must retain at their own expense an expert who is qualified to develop and implement a written sanitation control program, which will ensure that Defendants comply with cGMP.
(4) Defendants must notify the FDA of the expert's name and qualifications within five days of retaining the expert.
(5) Defendants' expert must develop an effective written sanitation control program acceptable to the FDA, which will meet certain minimum requirements for food-related operations.
(6) Defendants must obtain FDA approval of the expert's plan.
(7) Upon FDA approval, Defendants must make the written program available to all employees and assign responsibility and authority for implementing the program to an employee trained in sanitation control requirements.
(8) Defendants' expert must develop a written employee training program.
(9) Defendants' expert must conduct a comprehensive inspection of Defendants' facilities to determine whether Defendants have adequately established and implemented the written sanitation control program and brought their facilities into compliance. Defendants' expert must certify his or her conclusions in writing to the FDA. Once Defendants' expert makes this certification, the FDA would have the option to conduct its own inspection of the facilities at Defendants' expense and/or notify Defendants in writing that Defendants appear to be in compliance. Only then would Defendants be allowed to resume operations.
Going forward, Defendants would have responsibility for continuing the implementation of the sanitation control program and must obtain prior approval from the FDA for any changes or modifications to the program. Defendants would have an ongoing to duty to inform and train all of their employees on the requirements of the sanitation program as well as the provisions of the court order. Under the terms of the permanent injunction, the FDA would be permitted to inspect Defendants' facilities, without prior notice to Defendants, to ensure continuing compliance with the permanent injunction. Pursuant to the proposed injunction, this inspection
Furthermore, Defendants and any related party would be permanently enjoined from committing any act that would violate the FDCA, its implementing regulations, or the terms of the injunction itself. In the event that Defendants and/or their agents violate Section 331(a) or (k) of the FDCA, the FDA would have discretion to order Defendants to take appropriate action, including the immediate cessation of processing, preparing, packing, holding, and distributing of food. In the event that the FDA required Defendants to cease production, they would not be permitted to resume until the FDA certified that Defendants were in compliance with the terms of the injunction, FDA regulations, and the FDCA. If the FDA deemed it necessary, Defendants would be required to recall all articles of their products, and all costs of such a recall would be borne by Defendants.
The proposed injunction provides that all decisions and determinations specified are to be vested in the discretion of the FDA and that the agency's decisions will be final, subject only to review by this Court under the arbitrary and capricious standard set forth in 5 U.S.C. § 706(2)(A). No discovery may be had by either party. In the event Defendants sought to change ownership or alter their operations in any way that would affect Defendants' compliance with the injunction, Defendants would first be required to give the FDA thirty days written notice of such changes. Finally, this Court would retain jurisdiction over this action for the purpose of enforcing or modifying the terms of the injunction.
The parties fundamentally disagree over the applicable standard for granting injunctive relief. The government cites the Supreme Court's decision in United States v. W.T. Grant Co. and argues that it only has to show that Defendants violated the statute and there exists "some cognizable danger of recurrent violation."
In response, Defendants contend that the government must satisfy the traditional four-factor balancing test for permanent injunctive relief, showing (1) that it has suffered an irreparable injury; (2) that remedies available at law, such as monetary damages, are inadequate to compensate for that injury; (3) that, considering the balance of hardships between the
The Court holds that in order to obtain injunctive relief under the FDCA, the government need only prove that Defendants violated the Act and that there is a likelihood of future violations of the Act. Courts have held that the traditional four-factor test for permanent injunctive relief is not applicable in the FDCA context because the government is enforcing a statute to protect the public interest.
While it has never addressed this exact issue in the FDCA context, the Sixth Circuit has held that the government need not establish all of the traditional factors to obtain an injunction pursuant to federal statute where the statutory text "has replaced the traditional equitable factors with a different inquiry."
Applying the same reasoning here, the Court holds that the government is not required to meet the traditional four-factor test to enjoin violations of the FDCA. The Act grants the Court jurisdiction to issue an injunction simply "for cause shown."
In support of its request for a permanent injunction, the government argues that the Court should consider all of the violations committed by Defendants collectively in analyzing the issue. The government stresses Defendants' pattern of conduct, history of violations, the prior in rem seizure action, and the current violations at more than one facility. The government contends that without the injunction, "Defendants will almost certainly continue to operate under unsanitary conditions, just they did following the in rem seizure."
Just as with the issue of liability, the Court finds that separate consideration of each corporate Defendant is required at the remedies stage. As such, the Court must analyze the likelihood of AMC committing future violations as a separate and distinct issue from the likelihood of ICA committing future violations. Moreover, in the event the Court finds a likelihood of future violations as to a corporate Defendant, the Court will then need to consider what form of injunctive relief is appropriate under the circumstances as a remedy against that Defendant. The Court finds that oral argument on the likelihood of future violations and the proper scope of an injunction to prevent such violations would assist the Court in making its determination.
The government's Motion for Summary Judgment is
As for the remedy, the Court holds that in order to obtain injunctive relief, the United States need only prove that Defendants
City of Pontiac Gen. Emps.' Ret. Sys. v. Stryker Corp., 865 F.Supp.2d 811, 816 (W.D.Mich.2012) (citing FDA Form 483 Frequently Asked Questions http://www.fda.gov/ICECI/EnforcementActions/ucm256377.htm (last visited Mar. 30, 2012)); Pub. Pension Fund Group v. KV Pharm. Co., 705 F.Supp.2d 1088, 1100 (E.D.Mo.2010).
Defendants have not responded with any evidence to show that all of these samples came from the goods received in the contaminated shipment(s), which AMC had received only a short time before the inspection. Additionally, one of the photographs taken during the inspection depicts a product labeled as "Queen of the Meadow" and bearing the words "REJECT." See Id., ex. B-1 at p. 6 (D.E. # 26-2). The date on the label is July 30, 2009, more than one year before the inspection occurred. Id.